PAPPA and fetal growth restriction: The authors concluded that the risks for aneuploidies, structure abnormalities, preterm birth, and IUGR in women with PAPP-A levels <0.1 MoM were 6-, 36-, 1.8-, and 3.8 fold increased respectively compared to women with PAPP-A levels of 0.2-0.3 MoM.